The best dividend shares to buy right now

Rupert Hargreaves explains why he would buy these top dividend shares, considering their valuations and growth potential going forward.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Woman using laptop and working from home

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I am always looking for dividend shares to buy for my portfolio. Right now, I think investors are spoilt for choice when it comes to income investments. 

As such, here are a selection of companies that I believe are some of the best dividend shares to buy now. 

The best dividend shares

One sector I think is being particularly unfairly punished by the market is the homebuilding sector. 

Shares in companies like Taylor Wimpey and Persimmon have been under pressure following the government’s announcement that it would crack down on developers to help fund the country’s cladding crisis. 

However, according to analysts, the sell-off has gone too far. Analysts believe these companies have lost significantly more market value than they would have to pay out in the worst-case scenario. I think this presents an opportunity. While there is still a risk that they could be on the hook for billions in potential liabilities, low valuations offset some of this risk. 

That is why I would acquire both Taylor and Persimmon for my portfolio today. The former currently supports a potential dividend yield of 5.7%. The latter yields around 9%. On top of this, both companies have cash-rich balance 7.

As well as the homebuilders, I think Hikma and Coca-Cola HBC are also some of the best shares to buy now. 

I think both of these dividend shares have unique qualities, which makes them stand out from the competition. Hikma is one of the world’s largest producers of generic drugs. It has substantial economies of scale and resources to invest in developing new treatments. This is its competitive edge. 

Meanwhile, Coca-Cola HBC has the bottling contract for its namesake in Europe. This almost guarantees the company’s revenue stream, giving it the flexibility to invest in other business areas and return cash to investors. 

Having said all of the above, these companies are both exposed to risks. Challenges they could face in the future include rising cost inflation and competition. Even Coca-Cola HBC is not immune to competition in the soft drinks sector. It may need to increase its marketing spending to maintain its position in the industry. 

Despite these risks, I think both organisations appear attractive as dividend shares. Coca-Cola HBC currently supports a dividend yield of 2.9%, with room for growth as the company’s earnings expand. It has also been returning cash to investors by repurchasing shares. 

Hikma offers a dividend yield of 2%. The dividend payout is covered 3.5 times by earnings per share, leaving plenty of headroom for further payout increases in the years ahead as the company’s profits expand. 

With a potential for both income and profit growth, I think these groups are some of the best shares to buy now. Not just for their income credentials but for their growth potential as well. 

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has recommended Coca-Cola HBC and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »